within Pharmacolibrary.Drugs.ATC.D;

model D11AX24
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 2.47 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.0099,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Deoxycholic acid is a secondary bile acid naturally produced in the human body by intestinal bacteria from cholic acid. It is used as an injectable adipocytolytic agent for the reduction of moderate to severe submental fat (double chin) in adults. It is FDA-approved under the trade name Kybella and is not intended for use outside of localized subcutaneous fat reduction.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetics for adult healthy individuals treated with injectable deoxycholic acid for submental fat reduction. No direct publication of full pharmacokinetic model parameters in humans is available; estimates are based on regulatory reviews and secondary summaries.</p><h4>References</h4><ol><li><p>Chung, H, et al., &amp; Park, JY (2021). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Cholic Acid (MT921) after a Subcutaneous Injection in the Submental Area to Humans. <i>Pharmaceuticals (Basel, Switzerland)</i> 14(8) –. DOI:<a href=&quot;https://doi.org/10.3390/ph14080830&quot;>10.3390/ph14080830</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34451926/&quot;>https://pubmed.ncbi.nlm.nih.gov/34451926</a></p></li><li><p>Dayan, SH, et al., &amp; Beddingfield, FC (2016). Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental Fat. <i>Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]</i> 42 Suppl 1 S263–S270. DOI:<a href=&quot;https://doi.org/10.1097/DSS.0000000000000870&quot;>10.1097/DSS.0000000000000870</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27787266/&quot;>https://pubmed.ncbi.nlm.nih.gov/27787266</a></p></li><li><p>Walker, P, &amp; Lee, D (2015). A phase 1 pharmacokinetic study of ATX-101: serum lipids and adipokines following synthetic deoxycholic acid injections. <i>Journal of cosmetic dermatology</i> 14(1) 33–39. DOI:<a href=&quot;https://doi.org/10.1111/jocd.12122&quot;>10.1111/jocd.12122</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25684122/&quot;>https://pubmed.ncbi.nlm.nih.gov/25684122</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D11AX24;
